
Scott1775🇺🇸
48.4K posts

Scott1775🇺🇸
@Scott01251507
.Texan and American. Navy Patriot , Baptist , Biker. grandson of ww1 vet, son of ww2 vet ,Gold Star brother Viet Nam, Gold Star father Iraq. happily married.



BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal 84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION. Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995. The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology. A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole. Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability. At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either: No evidence of disease (32.8%) Tumor regression (15.6%) or Cancer stabilization (36.1%) Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months. Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments. This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential. With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required. In the meantime, many cancer patients are exercising their right to try. @twc_health @McCulloughFund @IIAR_Journals @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

🚨 Jill Biden on CBS: “I said in the beginning I won’t pardon Hunter… but then Trump was elected and we knew he would target him. We just couldn’t let our son go to jail on charges no one would go to jail for.” Translation: Rules for thee, but not for me. Hunter’s gun felonies, $1.4M tax evasion, and Burisma grift while Joe was point man on Ukraine? Totally fine. But Trump gets lawfare for years and they cry “persecution.” The Biden family’s entitlement is unmatched.




I'm in my very early 60s. The best President of my lifetime is Donald Trump. The best Vice President of my lifetime is JD Vance. The best SecDef/War of my lifetime is Pete Hegseth. The best SecState of my lifetime is Marco Rubio. The best SecTreasury of my lifetime is Scott Bessent. The best entrepreneur of my lifetime is Elon Musk. We truly live in a Golden Age.


He owned that wok! That's amazing! The fried rice is only $1!










🚨 WOW! It's now being reported nationwide that Spencer Pratt is seeing a "LAST-MINUTE SURGE" in the LA mayoral race A new poll just confirmed it: Pratt is in the MARGIN OF ERROR "The race is now a tossup." He could really do it! Pratt was NEVER supposed to get this far according to the LA machine 🔥 KEEP PUSHING!














